KR20040030783A - 마이코플라즈마 보비스 백신 및 동물에서의 폐렴 감소 방법 - Google Patents

마이코플라즈마 보비스 백신 및 동물에서의 폐렴 감소 방법 Download PDF

Info

Publication number
KR20040030783A
KR20040030783A KR10-2004-7000003A KR20047000003A KR20040030783A KR 20040030783 A KR20040030783 A KR 20040030783A KR 20047000003 A KR20047000003 A KR 20047000003A KR 20040030783 A KR20040030783 A KR 20040030783A
Authority
KR
South Korea
Prior art keywords
vorbis
vaccine
mycoplasma
mycoplasma bovis
challenge
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR10-2004-7000003A
Other languages
English (en)
Korean (ko)
Inventor
로빈 리 케이취
데이비드 로쓰 맥가빈
로버트 존 얀세이
Original Assignee
화이자 프로덕츠 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 화이자 프로덕츠 인크. filed Critical 화이자 프로덕츠 인크.
Publication of KR20040030783A publication Critical patent/KR20040030783A/ko
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/0241Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36Adaptation or attenuation of cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55577Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
KR10-2004-7000003A 2001-07-02 2002-06-27 마이코플라즈마 보비스 백신 및 동물에서의 폐렴 감소 방법 Ceased KR20040030783A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30263801P 2001-07-02 2001-07-02
US60/302,638 2001-07-02
PCT/IB2002/002514 WO2003004052A1 (en) 2001-07-02 2002-06-27 Mycoplasma bovis vaccine and methods of reducing pneumonia in animals

Publications (1)

Publication Number Publication Date
KR20040030783A true KR20040030783A (ko) 2004-04-09

Family

ID=23168600

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2004-7000003A Ceased KR20040030783A (ko) 2001-07-02 2002-06-27 마이코플라즈마 보비스 백신 및 동물에서의 폐렴 감소 방법

Country Status (31)

Country Link
US (1) US20030147914A1 (enExample)
EP (1) EP1401488A1 (enExample)
JP (1) JP2004536106A (enExample)
KR (1) KR20040030783A (enExample)
CN (1) CN1522152A (enExample)
AP (1) AP2002002568A0 (enExample)
AR (1) AR036125A1 (enExample)
BG (1) BG108496A (enExample)
BR (1) BR0210798A (enExample)
CA (1) CA2452580A1 (enExample)
CZ (1) CZ20033465A3 (enExample)
EA (1) EA200301324A1 (enExample)
GT (1) GT200200139A (enExample)
HN (1) HN2002000162A (enExample)
HR (1) HRP20031078A2 (enExample)
HU (1) HUP0501188A2 (enExample)
IL (1) IL159516A0 (enExample)
IS (1) IS7078A (enExample)
MA (1) MA27048A1 (enExample)
MX (1) MXPA03011815A (enExample)
NO (1) NO20035767L (enExample)
OA (1) OA12640A (enExample)
PA (1) PA8549801A1 (enExample)
PE (1) PE20030239A1 (enExample)
PL (1) PL373891A1 (enExample)
SK (1) SK15802003A3 (enExample)
TN (1) TNSN03154A1 (enExample)
UY (1) UY27365A1 (enExample)
WO (1) WO2003004052A1 (enExample)
YU (1) YU102103A (enExample)
ZA (1) ZA200309747B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179473B2 (en) 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
US7135561B2 (en) 2001-09-06 2006-11-14 Boehringer Ingelheim Vetmedica Gmbh Infectious bovine viral diarrhea virus clone
US7279166B2 (en) 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
SE0301436D0 (sv) * 2003-05-16 2003-05-16 Joakim Westberg New proteins
US7572455B2 (en) * 2004-05-19 2009-08-11 Boehringer Ingelheim Vetmedica Gmbh Vaccine comprising an attenuated pestivirus
US20090068223A1 (en) * 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
US20110059437A1 (en) * 2006-09-07 2011-03-10 Boehringer Ingelheim Vetmedica, Inc. Pcr-based genotyping
EP2377550B1 (en) 2006-09-11 2015-03-04 Zoetis P LLC Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins
UY31437A1 (es) * 2007-10-29 2009-05-29 Vacuna de mycoplasma bovis y métodos de uso de la misma
UY31930A (es) * 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
CA2729080C (en) * 2008-07-03 2018-09-11 Ricardo Rosenbusch Cattle vaccines
NZ591950A (en) * 2008-10-31 2012-12-21 Boehringer Ingelheim Vetmed Use of various antigens including antigens from mycoplasma bovis in multivalent vaccine composition
US8846054B2 (en) * 2009-01-09 2014-09-30 Boehringer Ingelheim Vetmedica, Inc. Method of treating pregnant cows and/or heifers
UY32570A (es) * 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
JP5968622B2 (ja) 2009-06-04 2016-08-10 国立感染症研究所長 マイコプラズマ感染症用ワクチン
CN102220263B (zh) * 2011-05-06 2012-10-03 华中农业大学 一种牛支原体致弱菌株及其应用
UA121193C2 (uk) 2012-12-28 2020-04-27 Бьорінгер Інгельхайм Ветмедіка Гмбх Спосіб одержання імуногенної композиції проти мікоплазми
CN104857509A (zh) * 2015-06-02 2015-08-26 福清市默克兽医院 牛支原体肺炎组织灭活疫苗的制备方法、配方及使用方法
EP3334454B1 (en) 2015-08-14 2022-10-19 Zoetis Services LLC Mycoplasma bovis compositions
CN105441368B (zh) * 2016-01-19 2019-01-01 福清市默克兽医院 一株牛支原体及其应用
CN106929452B (zh) * 2017-04-11 2020-06-12 河南省农业科学院畜牧兽医研究所 一株牛支原体及其应用
CN109022314B (zh) * 2018-08-06 2021-08-13 北京华夏兴洋生物科技有限公司 一株牛支原体及其在疫苗研制中的应用
CN110338138B (zh) * 2019-06-19 2021-04-06 山东省农业科学院奶牛研究中心 一种牛支原体感染豚鼠的动物模型构建方法及其应用
CN112301041B (zh) * 2020-10-09 2022-05-24 华中农业大学 牛支原体p21蛋白及其应用
CN113546162B (zh) * 2021-05-31 2023-07-18 江苏省农业科学院 一种支原体疫苗及其制备方法
CN113604492B (zh) * 2021-09-10 2023-07-07 苏州世诺生物技术有限公司 融合基因、融合蛋白及制备方法和牛支原体亚单位疫苗

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
JP2003513935A (ja) * 1999-11-08 2003-04-15 バイオミューン マイコプラズマ・ボビスに対するワクチンおよび使用方法
DE29921392U1 (de) * 1999-12-06 2000-03-16 Dr. Felgenträger & Co. Öko-Chem. und Pharma GmbH, 06862 Rodleben Mykoplasma-bovis-Kombinations-Vakzine für Rinder
US6548069B2 (en) * 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin

Also Published As

Publication number Publication date
TNSN03154A1 (fr) 2005-12-23
EP1401488A1 (en) 2004-03-31
US20030147914A1 (en) 2003-08-07
AR036125A1 (es) 2004-08-11
IL159516A0 (en) 2004-06-01
PA8549801A1 (es) 2003-09-17
CA2452580A1 (en) 2003-01-16
SK15802003A3 (sk) 2005-01-03
HUP0501188A2 (en) 2006-05-29
JP2004536106A (ja) 2004-12-02
PL373891A1 (en) 2005-09-19
CN1522152A (zh) 2004-08-18
AP2002002568A0 (en) 2002-06-30
MXPA03011815A (es) 2004-04-02
NO20035767L (no) 2004-01-30
ZA200309747B (en) 2005-05-27
WO2003004052A1 (en) 2003-01-16
EA200301324A1 (ru) 2004-12-30
PE20030239A1 (es) 2003-03-21
HN2002000162A (es) 2002-09-17
YU102103A (sh) 2006-05-25
UY27365A1 (es) 2003-04-30
HRP20031078A2 (en) 2005-08-31
MA27048A1 (fr) 2004-12-20
GT200200139A (es) 2003-02-13
IS7078A (is) 2003-12-15
OA12640A (en) 2006-06-15
BG108496A (en) 2005-02-28
BR0210798A (pt) 2006-05-23
CZ20033465A3 (cs) 2004-12-15

Similar Documents

Publication Publication Date Title
KR20040030783A (ko) 마이코플라즈마 보비스 백신 및 동물에서의 폐렴 감소 방법
KR101292874B1 (ko) 신규 백신 제형물
US7056492B2 (en) Mycoplasma hyopneumoniae vaccine and methods for reducing Mycoplasma bovis pneumonia in cattle
ES2312580T3 (es) Vacunacion en dosis unica con i mycoplasma hyopneumoniae/i.
US10772954B2 (en) Dual adjuvant vaccine compositions, preparation and uses
KR20040044942A (ko) 수의 백신 보조제로서의 인터루킨-12
JP3178720B2 (ja) パスツレラ・ムルトシダのトキソイドワクチン
KR20040031015A (ko) 마이코플라즈마 보비스 시험감염 모델, 엠. 보비스 투여방법 및 폐렴성 폐 병변 유도 방법
NZ199561A (en) Vaccine against enzootic abortion in ewes
Egerton et al. Effect of Quil A, a saponin derivative, on the response of sheep to alum precipitated Bacteroides nodosus vaccines
EP1387693B1 (en) Saponin inactivated mycoplasma vaccine
AU2002311568A1 (en) Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
AU2002304305B2 (en) Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle
HK1064617A (en) Mycoplasma bovis vaccine and methods of reducing pneumonia in animals
AU2002304305A1 (en) Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle
HK1134900B (en) One dose vaccination with (1) mycoplasma hyopneumoniae (/1)
HK1180224B (en) One dose vaccination with mycoplasma hyopneumoniae
HK1068250B (zh) 单剂量猪肺炎支原体疫苗

Legal Events

Date Code Title Description
A201 Request for examination
PA0105 International application

Patent event date: 20040102

Patent event code: PA01051R01D

Comment text: International Patent Application

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20051026

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20060413

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20051026

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I